Live Analyst Rating Changes 8035 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Vijay Kumar
EVR
Vijay Kumar
Wall Street Analyst
★★★☆☆
#1241
on 13Foresight · ranked by our own returns
58%
Success Rate
+6.0%
Average Return
36 of 62 calls profitable · -0.8% vs benchmark
📈 Across the calls we could measure, roughly 58% of Vijay Kumar's ratings turned a profit when each position was held for 2 year — averaging +6.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

140 Buy 35 Hold 0 Sell
Vijay's Stock Coverage 33 ratings · 2026-07-12
Company Date Position Consensus Price Target 2-Yr Return
CAI
Caris Life Sciences, Inc.
Jul 06, 2026 BUY Strong Buy
+65.7% avg upside
20 analysts
$25.00
47.07% Upside
-4.6%
TMO
Thermo Fisher
Jul 06, 2026 BUY Strong Buy
+11.5% avg upside
38 analysts
$570.00
8.14% Upside
+1.8%
WAT
Waters
Jul 06, 2026 BUY Strong Buy
+0.2% avg upside
30 analysts
$410.00
8.86% Upside
-0.7%
ZBH
Zimmer Biomet Holdings
Jul 06, 2026 BUY Buy
+21.9% avg upside
38 analysts
$110.00
20.42% Upside
+1.8%
PEN
Penumbra
Jul 06, 2026 BUY Buy
+3.9% avg upside
23 analysts
$320.00
0.52% Upside
-0.2%
IRTC
Irhythm Technologies
Jul 06, 2026 BUY Strong Buy
+44.9% avg upside
19 analysts
$150.00
29.07% Upside
-7.9%
GH
Guardant Health
Jul 06, 2026 BUY Strong Buy
-12.2% avg upside
31 analysts
$200.00
25.05% Upside
-5.2%
TWST
Twist Bioscience
Jul 06, 2026 HOLD Strong Buy
-17.7% avg upside
14 analysts
$102.00
12.54% Upside
-9.3%
AVTR
Avantor
Jul 06, 2026 HOLD Buy
+39.2% avg upside
26 analysts
$10.50
1.04% Upside
+0.2%
BLCO
Bausch + Lomb Corporation
Jul 06, 2026 HOLD Buy
+20.9% avg upside
19 analysts
$17.00
4.77% Upside
-2.6%
ABT
Abbott Laboratories
Jul 06, 2026 BUY Strong Buy
+24.2% avg upside
36 analysts
$112.00
19.18% Upside
-1.8%
A
Agilent
Jul 06, 2026 BUY Strong Buy
+10.6% avg upside
33 analysts
$148.00
10.16% Upside
+2.3%
BAX
Baxter International
Jul 06, 2026 BUY Hold
+32.1% avg upside
23 analysts
$24.00
6.10% Upside
+0.0%
BDX
Becton Dickinson
Jul 06, 2026 BUY Buy
+28.4% avg upside
25 analysts
$180.00
18.38% Upside
-2.3%
BSX
Boston Scientific
Jul 06, 2026 BUY Strong Buy
+69.5% avg upside
38 analysts
$65.00
45.17% Upside
+0.4%
ENOV
Enovis
Jul 06, 2026 BUY Strong Buy
+167.9% avg upside
37 analysts
$32.00
24.31% Upside
·
DHR
Danaher
Jul 06, 2026 BUY Strong Buy
+8.5% avg upside
45 analysts
$230.00
15.57% Upside
+2.8%
EW
Edwards Lifesciences
Jul 06, 2026 BUY Strong Buy
+6.7% avg upside
34 analysts
$100.00
8.50% Upside
-4.4%
ILMN
Illumina
Jul 06, 2026 BUY Buy
-19.1% avg upside
30 analysts
$200.00
5.11% Upside
-2.1%
ISRG
Intuitive Surgical
Jul 06, 2026 HOLD Strong Buy
+30.3% avg upside
36 analysts
$430.00
5.66% Upside
-6.0%
MDT
Medtronic
Jul 06, 2026 BUY Buy
+15.5% avg upside
38 analysts
$105.00
25.24% Upside
+0.9%
MTD
Mettler-Toledo
Jul 06, 2026 BUY Buy
-9.6% avg upside
18 analysts
$1350.00
4.24% Upside
+0.0%
RVTY
Revvity
Jul 06, 2026 BUY Buy
-5.5% avg upside
23 analysts
$125.00
11.29% Upside
-0.6%
SYK
Stryker
Jul 06, 2026 BUY Strong Buy
+14.5% avg upside
37 analysts
$350.00
6.13% Upside
+1.6%
PRCT
PROCEPT BioRobotics
Jun 24, 2026 BUY Buy
+78.2% avg upside
17 analysts
$30.00
43.69% Upside
+1.7%
NVCR
NovoCure
May 01, 2026 BUY Strong Buy
+200.0% avg upside
11 analysts
$20.00
22.67% Upside
+5.8%
GEHC
GE Healthcare Technologies Inc
Apr 30, 2026 BUY Buy
+27.0% avg upside
22 analysts
$80.00
23.68% Upside
+6.3%
AZTA
Azenta
Apr 06, 2026 BUY Buy
+84.9% avg upside
13 analysts
$35.00
38.02% Upside
+8.5%
WST
West Pharmaceutical Services
Feb 03, 2026 BUY Strong Buy
+0.7% avg upside
17 analysts
$320.00
9.59% Downside
+34.1%
OSUR
Orasure Technologies
May 19, 2025 HOLD Buy
+97.9% avg upside
11 analysts
$3.00
30.08% Downside
+63.5%
MLAB
Mesa Laboratories
Nov 12, 2024 BUY Buy
+47.5% avg upside
5 analysts
$150.00
56.91% Upside
-17.9%
HYPR
Hyperfine
May 12, 2023 BUY Strong Buy
+93.3% avg upside
7 analysts
$2.50
129.39% Upside
-48.9%
CEG
Constellation Energy Corporation
Nov 09, 2022 BUY Strong Buy
+34.2% avg upside
30 analysts
$93.00
62.93% Downside
+179.3%
🔒 28 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Vijay Kumar — Frequently Asked Questions
How accurate are Vijay Kumar's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Vijay's ratings were profitable over a one-year hold, with an average return of +2.9% per rating, or -2.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Vijay ranked on 13Foresight?
Vijay Kumar is currently ranked #1241 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Vijay cover?
Vijay most recently has ratings on CAI, TMO, WAT, ZBH, PEN, IRTC, GH, TWST, AVTR, BLCO, ABT, A and 21 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.